Nurse Practitioner · Dallas, TX
NPI
1750925137
Since 2019
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5939 Harry Hines Blvd Suite 700
Dallas, TX, 75389
Phone (214) 645-1919
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
346 services
Medicare patients, 2024
259
Average age 70
Drug cost, 2024
$986K
457 prescriptions
Company payments, 2025
$37.32
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessika Green was code 99214 (office e&m - established), 146 times for 130 patients. In total Jessika Green billed 346 services in 14 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 146 | 130 | $75.94 | $11K |
| 91200 Standard X-ray | Office | 75 | 75 | $19.68 | $1,476 |
| 99215 Office E&M - Established | Office | 52 | 48 | $105.40 | $5,481 |
| 99213 Office E&M - Established | Office | 39 | 38 | $54.20 | $2,114 |
By year: 2022 $24K for 338 services; 2023 $14K for 191 services; 2024 $23K for 346 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessika Green prescribed most often to Medicare patients was Carvedilol, with 57 prescriptions and refills. In total Jessika Green wrote 457 Medicare prescriptions that cost $986K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 57 | 129 | 26 | $403 |
| Spironolactone Generic | 48 | 97 | 19 | $530 |
| Lactulose Generic | 46 | 61 | 12 | $1,366 |
| Ursodiol Generic | 42 | 88 | 14 | $5,029 |
| Vemlidy Tenofovir Alafenamide | 34 | 34 | Under 11 | $51K |
| Omeprazole Generic | 28 | 48 | Under 11 | $555 |
| Furosemide Generic | 22 | 63 | 14 | $186 |
| Epclusa Sofosbuvir/Velpatasvir | 21 | 21 | Under 11 | $563K |
| Mavyret Glecaprevir/Pibrentasvir | 19 | 19 | Under 11 | $244K |
| Entecavir Generic | 17 | 24 | Under 11 | $6,660 |
| Tenofovir Disoproxil Fumarate Generic | 15 | 41 | Under 11 | $2,068 |
| Azathioprine Generic | 14 | 36 | Under 11 | $363 |
| Pantoprazole Sodium Generic | 13 | 13 | Under 11 | $83.56 |
| Esomeprazole Magnesium Generic | 12 | 12 | Under 11 | $113 |
Brand drugs: 91 claims; generic drugs: 366 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessika Green $37.32 ($37.32 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $23.8.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.